- Type / Class
- Equity / Common Stock
- Shares outstanding
- 20,788,527
- Total 13F shares
- 167,936,090
- Share change
- -1,816,792
- Total reported value
- $2,881,857,625
- Put/Call ratio
- 101%
- Price per share
- $17.16
- Number of holders
- 231
- Value change
- -$33,251,989
- Number of buys
- 99
- Number of sells
- 94
Quarterly Holders Quick Answers
What is CUSIP 640268108?
CUSIP 640268108 identifies NKTR - Nektar Therapeutics - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 640268108:
Top shareholders of NKTR - Nektar Therapeutics - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Invesco Ltd. |
13F
|
Company |
171%
|
35,449,394
|
$708,987,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
92%
|
19,027,136
|
$380,543,000 | — | 31 Mar 2021 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
87%
|
18,165,369
|
$363,307,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
86%
|
17,834,382
|
$356,688,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
80%
|
16,713,831
|
$334,276,000 | — | 31 Mar 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
55%
|
11,383,721
|
$227,674,000 | — | 31 Mar 2021 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
28%
|
5,858,316
|
$117,166,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
21%
|
4,378,595
|
$87,572,000 | — | 31 Mar 2021 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
20%
|
4,148,080
|
$82,962,000 | — | 31 Mar 2021 | |
| Bellevue Group AG |
13F
|
Company |
19%
|
3,954,604
|
$79,093,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
11%
|
2,326,729
|
$46,534,000 | — | 31 Mar 2021 | |
| Camber Capital Management LP |
13F
|
Company |
9.6%
|
2,000,000
|
$40,000,000 | — | 31 Mar 2021 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
9.5%
|
1,966,238
|
$39,325,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
8.9%
|
1,854,692
|
$37,094,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
8.3%
|
1,722,058
|
$34,440,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
7.3%
|
1,515,952
|
$30,319,000 | — | 31 Mar 2021 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
6.3%
|
1,307,196
|
$26,144,000 | — | 31 Mar 2021 | |
| Duquesne Family Office LLC |
13F
|
Company |
4.8%
|
1,000,000
|
$20,000,000 | — | 31 Mar 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4.6%
|
951,931
|
$19,036,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
4.2%
|
871,415
|
$17,429,000 | — | 31 Mar 2021 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
3.2%
|
665,756
|
$13,315,000 | — | 31 Mar 2021 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
2.7%
|
566,082
|
$11,322,000 | — | 31 Mar 2021 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.6%
|
532,164
|
$10,643,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
2.5%
|
520,793
|
$10,416,000 | — | 31 Mar 2021 | |
| MORGAN STANLEY |
13F
|
Company |
2.5%
|
519,130
|
$10,384,000 | — | 31 Mar 2021 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
2.4%
|
502,713
|
$10,054,000 | — | 31 Mar 2021 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
2.4%
|
498,425
|
$9,968,000 | — | 31 Mar 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.2%
|
459,974
|
$9,200,000 | — | 31 Mar 2021 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
2.1%
|
445,922
|
$8,918,000 | — | 31 Mar 2021 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2%
|
414,911
|
$8,299,000 | — | 31 Mar 2021 | |
| Swiss National Bank |
13F
|
Company |
2%
|
409,800
|
$8,196,000 | — | 31 Mar 2021 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
1.9%
|
397,797
|
$7,956,000 | — | 31 Mar 2021 | |
| OSTERWEIS CAPITAL MANAGEMENT INC |
13F
|
Company |
1.9%
|
394,929
|
$7,899,000 | — | 31 Mar 2021 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
1.8%
|
381,600
|
$7,632,000 | — | 31 Mar 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
1.6%
|
330,051
|
$6,601,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
1.4%
|
301,061
|
$6,021,000 | — | 31 Mar 2021 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.4%
|
283,194
|
$5,664,000 | — | 31 Mar 2021 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
1.3%
|
276,223
|
$5,524,000 | — | 31 Mar 2021 | |
| US BANCORP \DE\ |
13F
|
Company |
1.3%
|
269,294
|
$5,386,000 | — | 31 Mar 2021 | |
| Legal & General Group Plc |
13F
|
Company |
1.3%
|
264,768
|
$5,295,000 | — | 31 Mar 2021 | |
| Hennion & Walsh Asset Management, Inc. |
13F
|
Company |
1.3%
|
264,701
|
$5,294,000 | — | 31 Mar 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
1.3%
|
263,949
|
$5,279,000 | — | 31 Mar 2021 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
252,586
|
$5,051,720 | — | 31 Mar 2021 | |
| S.c.a. Candriam |
13F
|
Individual |
1.5%
|
306,085
|
$4,998,000 | — | 31 Mar 2021 | |
| Retirement Systems of Alabama |
13F
|
Company |
1.1%
|
237,789
|
$4,756,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
1.1%
|
225,124
|
$4,503,000 | — | 31 Mar 2021 | |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM |
13F
|
Company |
1.1%
|
223,608
|
$4,472,000 | — | 31 Mar 2021 | |
| York State Teachers Retirement System New |
13F
|
Individual |
1%
|
214,200
|
$4,284,000 | — | 31 Mar 2021 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
1%
|
210,036
|
$4,200,000 | — | 31 Mar 2021 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.98%
|
204,383
|
$4,088,000 | — | 31 Mar 2021 |
Institutional Holders of Nektar Therapeutics - Common Stock (NKTR) as of Q2 2021
As of 30 Jun 2021,
Nektar Therapeutics - Common Stock (NKTR) was held by
231 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
167,936,090 shares.
The largest 10 holders included
Invesco Ltd., BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, MAVERICK CAPITAL LTD, STATE STREET CORP, Bellevue Group AG, and Camber Capital Management LP.
This page lists
232
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
224
Q2 2021 holders
231
Holder diff
7
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.